Carregant...
Bupropion, Alone and in Combination with Naltrexone, Blunts Binge-Like Ethanol Drinking and Intake Following Chronic Intermittent Access to Ethanol in Male C57BL/6J Mice
BACKGROUND: Regular binge drinking is associated with numerous adverse consequences yet the U.S. Food and Drug Administration (FDA) has approved only 4 medications for the treatment of alcohol use disorders (AUDs), and none have been specifically targeted for treating binge drinking. Here we assesse...
Guardat en:
| Publicat a: | Alcohol Clin Exp Res |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6502646/ https://ncbi.nlm.nih.gov/pubmed/30817015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/acer.13992 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|